chrisvoncsefalvay/vaers-outcomes huggingface dataset:
really tired; injection I got a big lump there; my arm hurts and it's itching; my arm hurts and it's itching; This is a spontaneous report from a contactable consumer (Patient). A 64-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH, solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on Aug2021 (age at the time of vaccination 64-years-old), as a single dose for covid-19 immunization. Medical history included, had allergic reactions, not to vaccines but to IV antibiotics, anaphylactic reaction, type 1 diabetes mellitus, and cardiac failure congestive, from an unknown date and unknown if ongoing. patient had a lot of underlying things. The patient's concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, on an unspecified date (age at the time of vaccination 64-years-old), as a single dose for COVID-19 immunization and experienced mild chill, little bit of body aches. Patient had her first dose of Pfizer Covid-19 Vaccine a month ago, and her second dose of Pfizer Covid-19 Vaccine a week ago today. After the first dose of Pfizer Covid-19 Vaccine she was fine, it doesn't matter, but she had a mild chill and a little bit of body aches for an hour and then she was good. After the second dose of Pfizer Covid-19 Vaccine she felt pretty good, just really tired at first, but no other symptoms for either first or second doses, not even arm pain. She has been feeling ok. On an unspecified date Aug2021, the patient experienced really tired, injection I got a big lump there, my arm hurts and it's itching. Caller's daughter is a nurse and said she hadn't heard of that with Pfizer Covid-19 Vaccine. Patient son was immunocompromised, and his physician ordered Covid antibody tests to see if it worked. It came back negative. was there any test that's recommended to see if it worked? Son was 30 years of age. He received both doses of product. Negative antibody test that the lab provides to see if you have been exposed to covid or have covid and created antibodies. Patient was told by the lab that it was not recommended. Special needs and immunocompromised patient, the antibody test came back negative. Patient sister had a different vaccine (Moderna) and she had a reaction "covid arm", rash red all the way down after the fact. Started yesterday out of the blue, day 6. Itching a bit. patient was allergic to everything, have had anaphylaxis to several important things. Symptom wise product seemed to be the best. The outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.  Follow-Up (11Oct2021): Follow-up activities closed. Batch/lot number not available for [Vaccine BNT162B2].
I have no memory of the day of the vaccine and barely memory for the day after. I still can't remember anything from the two days., so I believe this is permanent memory loss. I could not fine the Johnson & Johnson vaccine on the drop down.
pain in lt arm since 15OCT96;warm soaks, NSAIDS;no fever, no neuro changes;
I got Covid arm with both the 1st and 2nd shot (lot numbers not documented on the vaccine card). With the 1st shot (IM LA) no reaction until day 7. It turned bright red and quickly grew in size to 5 inches. It was very red and hot. I called the doctor's office right away. I was prescribed a prednisone taper. The redness started to recede and it kept me from getting rashes on other parts of my body. I was on prednisone for 7 days. The itching resolved within 48 hours and  the covid arm resolve within a few days. With the 2nd dose vaccine (IM RA),  the covid arm appeared on day 2. It was a larger area and it was not bright red, fiery rash. I did get a rash on my chest and on the side that I had the shot. I was instructed to take Benadryl for 1 week and to take it 1 hour before the vaccine to minimize my reaction. It took about a week for the covid arm to resolve. The rash on my chest took the longest the resolve.
Noticed Paresthesias on left side of face Tuesday evening at 9:30pm.  It dissipated over the next hour.  However, I woke up at 3:00 am and then the numbness was all over the left side of my face. I went to the ER.
None known. 7/2/09 Medical Examiner report received. COD - Sudden infant death syndrome (SIDS).
Had mild Carpel tunnel prior to vaccine.  Now I?m in pain every night. I have to wear a brace and take pain medication.   Sometimes I?m numb up to my shoulder.
Pt presented with an allergic reaction after multiple vaccines.  Reaction described as whelts scattered on face, erythema on neck.
COVID positive 11/17/2021. Patient fully vaccinated. Admitting dx shortness of breath.  Pneumonia due to COVID-19.  Elevated troponin. This patient is a 76-year-old gentleman with past medical history of diabetes, hypertension, chronic kidney disease, presented to the hospital with shortness of breath, fatigue, weakness 5 to 6 days before admission. The patient reported that he was vaccinated with Johnson and Johnson before, found to have COVID-19 positive.  Vitals stable.  EKG, normal sinus rhythm. CT of the chest showed no PE, patchy ground-glass airspace abnormalities. Blood work was done reviewed and his D-dimer was 686.  Due to his presentation, the patient was seen and evaluated by pulmonologist andInfectious Disease.  He received appropriate treatment with dexamethasone and Lovenox.  The patient had elevated troponin.  EKG was done and reviewed. 2D echo, ejection fraction 60%. Pt discharged to home.
Initial misuse report received from a healthcare professional on 30 January 2014. The cases were received at agency on 21 March 2014. It was reported that less than 3 years of age patient (no other information was reported) had received 0.5 ml dose of FLUZONE QIV on unspecified date. No adverse event was reported. List of documents held by sender: none.
left eye started getting numb, the eyelid and then down her face to the top lip, about 1/3 of the mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Jan2021 (Lot number: EC1283) at the age of 78 years as dose number unknown for covid-19 immunisation. Relevant medical history included: "High blood pressure" (ongoing), notes: Onset date unknown other diagnosed while she was in her 60s.; "Corneal dystrophy", start date: 2007 (ongoing), notes: Chronic condition, probably hereditary; "Allergies" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE taken for hypertension (ongoing); ATORVASTATIN taken for hypertension (ongoing). The following information was reported: HYPOAESTHESIA (non-serious) with onset 22Jan2021, outcome "recovered" (22Jan2021), described as "left eye started getting numb, the eyelid and then down her face to the top lip, about 1/3 of the mouth". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible. No further information is expected.
The day after getting the 4 dose, I experienced the "common" side effects of headache and fatigue. This lasted throughout the day. Approximately  9:00 pm  that evening (4/5), my throat was extremely sore (winced when swallowing) and my throat was swollen (i.e. breathing was difficult, followed by some coughing). This lasted 8-10 hours until morning. Sore throat subsided, but voice was scratchy. No fever at any time.
Pt states normal pain for about 4 days then started with itching and small red spot. Then redness spread and continued to itch and was warm to touch on day 5-6. Pt was treated with KEFLEX 500 for possible cellulitis said she is traveling.
This spontaneous report was received from Nurse refers to a patient of unknown age and gender. On 25-AUG-2015 the patient was vaccinated with PROQUAD (Merck) (dose, route, frequency and lot # unspecified). Nurse reported PROQUAD (Merck) which expired on 18-AUG-2015 which was inadvertently administered to a patient on 25-AUG-2015. No adverse effects reported. No additional information to report. Additional information has been requested.
This is in follow-up to report(s) previously submitted on 9/2/2011. Information has been received from an office manager and an office worker concerning an 88 year old female patient, who on 23-AUG-2011, was vaccinated with a one time dose of ZOSTAVAX (Merck) (Lot # 671017/0751AA, Exp. Date: 12-AUG-2012) 0.65 ml, subcutaneously. The office manager and office worker reported that on 23-AUG-2011, the patient experienced shortness of breath, swelling of the face and lips and the patient was hospitalized on the same date. It was unspecified if the patient received any treatment for the events. At the time of the report, patient's outcome was unknown. Follow up information has been received concerning an 88 year old female with anxiety and cardiac failure congestive and no illness at the time of vaccination, who on 24-AUG-2011 recovered from shortness of breath, swelling of the face and swelling of lips. No further information is available.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Jan2021 as dose 1, single (Lot number: EL9263), on 17Feb2021 as dose 2, single (Lot number: EL9267), on 28Aug2021 as dose 3 (booster), single (Lot number: EW0187) and on 28May2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 79 years for covid-19 immunisation. The patient's relevant medical history included: "thyroidectomy", start date: 2006, stop date: 2006, notes: Other medical history: thyroidectomy 2006; "osteoporosis" (unspecified if ongoing), notes: Other medical history: have osteoporosis; "labile blood pressure" (unspecified if ongoing), notes: Other medical history: labile blood pressure; "hip repair", start date: 2006, stop date: 2006, notes: Other medical history: 2016 hip repair; "appendectomy", start date: 2006, stop date: 2006, notes: Other medical history: 2006 appendectomy. Concomitant medication(s) included: SYNTHROID, start date: May2006; SERTRALINE, start date: Jan2017; AMLODIPINE, start date: Jul2022. Past drug history included: Septra, reaction(s): "Known allergies: septra", notes: Known allergies: septra; Demerol, reaction(s): "Known allergies: demerol", notes: Known allergies: demerol. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 with with Paxlovid from 13Jul2022 to 18Jul2022.
Headache, neck pain 2 hours after injection. C/O (L) deltoid being sore. Next AM/day, vomiting.
Yesterday and today I'm having diarrhea; This spontaneous case was reported by a physician and describes the occurrence of DIARRHOEA (Yesterday and today I'm having diarrhea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Yesterday and today I'm having diarrhea). At the time of the report, DIARRHOEA (Yesterday and today I'm having diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No Treatment  medication was provided.   Reporter did not allow further contact
about 12 hours after receiving vaccine, I experienced EXTREME cold. My body could not get warm. I shook violently all over my body. I took tylenol. Then, I experienced extreme heat and could not get cold. I felt like I had a fever and took some tylenol. I did not take my temperature. I started experiencing chest tightness. It feels funny in my chest like I cannot breathe fully. Everything has gone away except for the chest tightness.
p/vax pt w/a red, raised, itchy, & burning bullseye rash below the inj site way down past elbow;had chills, fatigue & h/a lasting almost 2wk;arm still burns & itches from time to time;pt found that was falling asleep @ work & while driving;
Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Shakiness-Severe, Systemic: Visual Changes/Disturbances-Severe, Additional Details: Vaccination was administered, within 10 min patient became unresponsive and appeared to lose conciousness. upon immediate assessment no signs of anaphylaxis were present, 911 was called. pt felt very warm to the touch and lost control of bladder. mother mentioned pt had passed out 7/14 at home but no prior history of any events. no reaction to any previous vaccines. paramedics arrived and took over pt was released under care of mother with suspision of dehydration
Terrible migraines; Dizzyness; . This spontaneous case was reported by an other and describes the occurrence of MIGRAINE (Terrible migraines) and DIZZINESS (Dizzyness) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Terrible migraines) and DIZZINESS (Dizzyness). At the time of the report, MIGRAINE (Terrible migraines) had not resolved and DIZZINESS (Dizzyness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Jul-2021 and was forwarded to Moderna on 16-Jul-2021.    . This spontaneous case was reported by an other and describes the occurrence of MIGRAINE (Terrible migraines) and DIZZINESS (Dizzyness) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Terrible migraines) and DIZZINESS (Dizzyness). At the time of the report, MIGRAINE (Terrible migraines) had not resolved and DIZZINESS (Dizzyness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Patient was due to receive 2nd dose of vaccine but inadvertently received a dose of different manufacturer.  Patient sat in observation for 15 minutes with no issue.  Pharmacist attempted to call patient and left a message with no return as of 30 minutes later (time of reporting).
Dizziness  diaphoresis  Narrative: Employee in vaccine clinic and started to feel dizzy after receiving  first dose of the COVID vaccine. He lied down on the exam table and water was  give. Initial BP 103/66, HR 90, Repeat 10 at 11:50 minutes later 113/82, HR 86;  repeat at 12noon was 120/82, HR 80. He was diaphoretic but this resolved after  10 minutes. He recovered for 30 minutes and he reported feeling better and well  enough to return to work.
Information has been received from a physician's assistant concerning a female (age unknown) who on an unspecified date was vaccinated intramuscularly with a 0.5 ml first dose of Gardasil. Subsequently the patient fainted. At the time of this report, the outcome was unknown. No product quality complaint was involved. This is one of two reports from the same source. No further information is available. 10/08/07 This is in follow-up to report(s) previously submitted on 7/16/2007. Information has been received from a physician's assistant concerning a female (age unknown) who on an unspecified date was vaccinated intramuscularly with a 0.5 ml first dose of GARDASIL. An unknown vaccination was administered at the same appointment. Subsequently the patient fainted. At the time of this report, the outcome was unknown. No product quality complaint was involved. This is one of two reports from the same source. No further information is available.
Left deltoid swollen, red, warm to touch. Prednisone 10mg - take on tablet daily with food - taper inj dose: 6mg, 6mg, 4mg, 4mg, 2mg, 2mg, stop.
102.3 Fever 10hrs after injection, chills, headache, difficulty moving arm, aching in all joints and muscles, swelling of hand
I experienced an upper torso rash and high fever. I rested and took Tylenol along with putting Hydrocortisone cream on the rash and did not seek the care of my PCP or other Healthcare Professional.
I developed shingles a week following vaccination on the back of my upper right thigh. Originally it was misdiagnosed when I went to Urgent care before later being diagnosed as shingles by my dermatologist. I had a series of red slightly painful and itchy bumps on my thigh that were in a curved line, and originally my treatment was only using a topical cream provided by the urgent care doctors. By the time of my dermatologist appointment a few weeks later it had mostly subsided and has since faded away.
HEADACHE; BODY ACHE; RED DOTS ON THE FACE; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered to left arm on 30-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 31-MAR-2021, the subject experienced body ache. On 31-MAR-2021, the subject experienced red dots on the face. On 31-MAR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, and fever on 2021, had not recovered from headache, and the outcome of red dots on the face was not reported. This report was non-serious.
This spontaneous report was received from a nurse referring to multiple unspecified patients of unknown demographics. Information about the patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date, the patients were inadvertently vaccinated with improperly stored doses of ZOSTAVAX, lot # L012475 with expiration date 10-JUL-2016 and lot # L012476 with expiration date 10-JUL-2016, (dose and route of administration were not provided). Concomitant medication was not reported. No adverse effects reported. Temperature: 6F; time frame: 15 hours. There is reported a previous temperature excursion, the highest temperature reached was 12F for a cumulative time out of range of 51 hours and 32 minutes. This is one of two reports received from the same source. Additional information is not expected since no consent was given to reach follow up.
+COVID test on 6/202/21 after completing vaccine series Pfizer COVID vaccine on 3/24/21 and 4/14/21
New employee was given the Tdap instead of flu vaccine.  New employee did not have any adverse event after receiving the Tdap.
This spontaneous report as receive from a pharmacist refers to a 27 year old patient of unknown gender. Medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL. Dose, route, lot number and expiration date were not reported. No adverse effects were reported. Patient want to complete the GARDASIL vaccination series. Additional information has been requested. No allowed to contact physician.
fever (101), slight nausea, body aches/pain (sharp pains in joints)  These lasted throughout the day after the 2nd vaccination. Everything was back to normal the next day.
on 17OCT pt contacted MD re: red & itchy skin, blotches on torso & legs; pt seen by MD on 18OCT & 19OCT told to d/c Naprosyn (as poss cause) & given DPH; med helped & blotches became less red & itchy; pt seen by RN 26OCT92-no itching, blotc
Incident Description: On 25Aug2023, at approximately 1502, an incident occurred involving MAs. MA mistakenly pulled out the incorrect vaccine (Quadracel instead of Pentacel) from the medication storage area, and MA administered the vaccine without properly verifying if it was the correct one as ordered by the doctor.  Sequence of Events: 1. MA, while preparing for the vaccination procedure, retrieved a vial of Quadracel from the medication storage area. 2. Due to a momentary lapse in concentration or confusion, MA inadvertently selected the wrong vaccine, which was not the one prescribed by the doctor for the patient. 3. MA, who was responsible for administering the vaccine, did not double-check the vial to ensure it matched the doctor's order. 4. MA proceeded to administer the vaccine to the patient without realizing that it was the incorrect one.  Immediate Actions Taken: 1. As soon as the error was identified, MA immediately informed the doctor in charge of the patient's care. 2. The patient was closely monitored for any adverse reactions or side effects resulting from the administration of the incorrect vaccine. 3. The doctor was promptly notified of the incident and provided with all relevant details. 4. The patient's medical records were updated to reflect the incident, including the type of vaccine administered and the incorrect vaccine that was pulled out.  Follow-up Actions: 1. Both MAs were counseled regarding the importance of double-checking medications and vaccines before administration. 2. MA was reminded to exercise caution and attentiveness when retrieving medications from the storage area to prevent similar incidents in the future. 3. MA received additional training on medication verification protocols and the importance of adhering to doctor's orders. 4. The incident was reported for further investigation and analysis to identify any system or process failures that may have contributed to the incident.